Trends in Atopic Dermatitis Management:
Comparison of 1990-1997 to 2003-2012
Back by popular demand, Dr. Steven Feldman, Professor of Dermatology, Pathology and Public Health joins host Dr. Adam Friedman from GW School of Medicine to review his recent database dive entitled "Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012." What new trends, both good and bad, have emerged? What can we expect and hope for the future of AD care? What tricks of th …
Comparison of 1990-1997 to 2003-2012
Back by popular demand, Dr. Steven Feldman, Professor of Dermatology, Pathology and Public Health joins host Dr. Adam Friedman from GW School of Medicine to review his recent database dive entitled "Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012." What new trends, both good and bad, have emerged? What can we expect and hope for the future of AD care? What tricks of th … Continue reading "Trends in Atopic Dermatitis Management:
Comparison of 1990-1997 to 2003-2012"
In the newest JDD Podcast, "Pledge to Protect? Highlighting Flaws with the Isotretinoin Safety Monitoring", Ask the Investigator, host Dr. Adam Friedman of GW School of Medicine and Health Sciences is joined by Albert Einstein College of Medicine Chief of Dermatology Dr. Steven Cohen for a throw back podcast covering his landmark 2016 JDD study entitled "iPLEDGE Weaknesses: Is It Time to Address t … 
Peter A. Lio, MD of Medical Dermatology Associates of Chicago shares his thoughts with us on his recent JDD podcast. Read below, then listen to Combo is King: Therapeutic Synergy in Dermatology (scroll to the second row of recordings).
If I am a resident, why should I listen to this podcast?
As a resident, one quickly gets used to a steep learning curve, but it turns out that residency is only t … 